Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Dasatinib Resistance in CML Patients. Identification of Novel BCR-ABL Kinase Domain Mutation.

Yelena Krijanovski, MD, Nicholas Donato, PhD, Alfonso Quintas-Cardama, MD, Jorge Cortes, MD, Moshe Talpaz, MD

Blood (2007) 110 (11): 1957.

https://doi.org/10.1182/blood.V110.11.1957.1957

Published: 2007

Journal Articles

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

Zia Shariat-Madar, Fakhri Mahdi, Mark Warnock, Jonathon W. Homeister, Sujata Srikanth, Yelena Krijanovski, Laine J. Murphey, Ayad A. Jaffa, Alvin H. Schmaier

Blood (2006) 108 (1): 192–199.

https://doi.org/10.1182/blood-2006-01-0094

Published: 2006

Journal Articles

Angiotensin Receptor 2 Over-Expression: A Novel Physiologic Mechanism for Thrombosis Protection.

Ziaeddin Shariat-Madar, PhD, Mark Warnock, MA, Fakhri Mahdi, MA, Sujata Srikanth, MA, Yelena Krijanovski, MD, Alvin H. Schmaier, MD

Blood (2004) 104 (11): 801.

https://doi.org/10.1182/blood.V104.11.801.801

Published: 2004

Journal Articles

Mapping the Interaction of Peptide RPPGF with the Exodomain on Human Protease Activated Receptor 4 (PAR4).

Marvin T. Nieman, PhD, Eileen Pagan-Ramos, PhD, Mark Warnock, MA, Yelena Krijanovski, MD, Ahmed A.K. Hasan, MD, PhD, Alvin H. Schmaier, MD

Blood (2004) 104 (11): 1847.

https://doi.org/10.1182/blood.V104.11.1847.1847

Published: 2004

Journal Articles

Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression

Yelena Krijanovski, Valerie Proulle, Fakhri Mahdi, Marie Dreyfus, Werner Müller-Esterl, Alvin H. Schmaier

Blood (2003) 101 (11): 4430–4436.

https://doi.org/10.1182/blood-2002-11-3329

Published: 2003

NARROW

Dasatinib Resistance in CML Patients. Identification of Novel BCR-ABL Kinase Domain Mutation.

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

Angiotensin Receptor 2 Over-Expression: A Novel Physiologic Mechanism for Thrombosis Protection.

Mapping the Interaction of Peptide RPPGF with the Exodomain on Human Protease Activated Receptor 4 (PAR4).

Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression

Email alerts

ASH Publications

American Society of Hematology

Dasatinib Resistance in CML Patients. Identification of Novel BCR-ABL Kinase Domain Mutation.

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

Angiotensin Receptor 2 Over-Expression: A Novel Physiologic Mechanism for Thrombosis Protection.

Mapping the Interaction of Peptide RPPGF with the Exodomain on Human Protease Activated Receptor 4 (PAR4).

Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only